2002
DOI: 10.1067/mva.2002.121850
|View full text |Cite
|
Sign up to set email alerts
|

Limitations in the use of rifampicin-gelatin grafts against virulent organisms

Abstract: These results suggested that rifampicin-gelatin grafts are clearly valid for S epidermidis infection, whereas no efficacy was recognized against either MRSA or E coli graft infection because of early development of high minimal inhibitory concentration MRSA strains or poor susceptibility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
41
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(42 citation statements)
references
References 22 publications
1
41
0
Order By: Relevance
“…However, MRSA has been reported to demonstrate no bacterial antibiotic susceptibility to 0.1% rifampicin-gelatin grafts according to the fi ndings of an in vitro susceptibility test. 30 Other studies in the literature confi rmed the effi cacy of gelatin-sealed grafts that were prebonded with 1.3% rifampin and 1.7% tobramycin in resisting infection with S. aureus in a dog model (Table 4). 31,32 However, silver grafts have been clearly shown to have better in vitro activity against a broad spectrum of bacteria.…”
Section: Discussionmentioning
confidence: 93%
“…However, MRSA has been reported to demonstrate no bacterial antibiotic susceptibility to 0.1% rifampicin-gelatin grafts according to the fi ndings of an in vitro susceptibility test. 30 Other studies in the literature confi rmed the effi cacy of gelatin-sealed grafts that were prebonded with 1.3% rifampin and 1.7% tobramycin in resisting infection with S. aureus in a dog model (Table 4). 31,32 However, silver grafts have been clearly shown to have better in vitro activity against a broad spectrum of bacteria.…”
Section: Discussionmentioning
confidence: 93%
“…For in situ Dacron graft replacement, patients have a 30-day operative mortality of 17 % [ 29 ]. A 30-day mortality for all cryopreserved arterial grafts is 7.5 % [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Its copolymers, lactides and glycolide are getting increasing attention because of their controllable biodegradation rates in the desirable ranges (slower) and also more suitable and tailor-made mechanical properties (more flexible and softer) for some applications such as long-term drug delivery and tissue repair and regeneration [10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%